Medical Oncologist
CION Cancer Clinics
HCC in a transplanted or previously treated liver | CION Cancer Clinics
Liver cancer can return after surgery, ablation, TACE or a transplant, and a new tumour can also grow in a liver that is still damaged. A new spot on a follow-up scan is not always the old cancer back. This page explains the difference, how doctors check a new finding, which treatments can be used again and why a transplant changes the choices. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can liver cancer come back after it has been treated?
- Is it the old cancer back, or a new tumour?
- What happens after a follow-up scan shows something new?
- Which treatments can be used again?
- Why is treatment different in a transplanted liver?
- What families often fear, and what is actually true
- What this page cannot tell you
- Common questions about HCC after treatment
The short answer
Can liver cancer come back after it has been treated?
Yes. Hepatocellular carcinoma (HCC) can return after surgery, ablation, TACE or even a liver transplant, and a new spot on a follow-up scan is one of the commonest things people in follow-up face. A new spot does not always mean the old cancer has returned. In a liver still damaged by hepatitis or cirrhosis, a completely new tumour can grow.
This page is about HCC, the cancer that starts in the main liver cells. If you were treated for cancer that spread to the liver from the bowel or elsewhere, follow-up is different, and your own cancer's pages will help more.
Why this happens more with liver cancer
Most cancers grow in an otherwise healthy organ. HCC usually grows in a liver that has been injured for years. Removing or destroying one tumour does not repair the rest of the liver. The same damage that produced the first tumour can produce another. That is why follow-up after liver cancer treatment is closer and lasts longer than for many other cancers.
Finding a new tumour early, while it is small, is the whole point of follow-up. It often still leaves real options.Two different things
Is it the old cancer back, or a new tumour?
Doctors separate the two because they behave differently and can be treated differently. Often the answer is a judgement, not a certainty.
True recurrence
Cancer cells from the first tumour survived treatment, either at the edge of the treated area or as tiny deposits elsewhere in the liver that were too small to see. They tend to show up sooner after treatment.
Often looks like
- Growth at the edge of an old ablation or TACE area
- Several small spots near the original site
- Appearing within the first stretch of follow-up
A new tumour in a damaged liver
A separate HCC arising from the same underlying liver disease. It tends to show up later, sometimes after many years of clear scans, and can be in a different part of the liver.
Recurrence after a transplant
A transplant replaces the diseased liver, so new tumours from old liver damage are not the main worry. Any cancer that returns came from cells that had already escaped before the operation. It can appear in the new liver, the lungs, bones or elsewhere.
Something that is not cancer
Scars, inflammation and changes after treatment can look worrying on a scan. Not every new finding is a tumour. That is why your team may ask for a different scan or a repeat scan before deciding.
Not sure whether this applies to you?
Ask an oncologistWhen a new spot is found
What happens after a follow-up scan shows something new?
Comparing with every old scan
The radiologist lays the new scan beside the previous ones. Where the spot is, and how it takes up contrast dye, helps tell recurrence from a new tumour or a treatment scar. Bring all your old CDs and reports.
Checking AFP and liver function
AFP, a protein that HCC often makes, may rise again. Bilirubin, albumin and clotting tests show how much reserve the liver still has, which decides what treatment is safe.
Looking outside the liver
A chest CT, and sometimes a bone scan or PET-CT, checks whether the cancer has spread beyond the liver. CION arranges these through accredited diagnostic partners.
A biopsy only if it changes the plan
When the scan pattern is typical, a needle sample is often not needed. It is taken when the picture is unclear or when tissue could open a treatment option.
The tumour board reviews the options
Your case goes back to the multidisciplinary tumour board, which weighs the new finding, the earlier treatment and your liver function before recommending a plan.
Side by side
Which treatments can be used again?
What you had before
What may be considered now
Liver resection
A repeat
resection if enough healthy liver is left, ablation, TACE, or a
salvage transplant for carefully selected people
Ablation
Repeat ablation, surgery, or TACE, depending on
where the new tumour sits
TACE
Further TACE while it keeps working and the liver
copes; systemic treatment when it stops working
Liver transplant
Surgery or local treatment for a single
deposit; systemic treatment chosen with the transplant team
Systemic treatment
A different medicine, often called second-line
treatment, if the liver and fitness allow
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
After a transplant
Why is treatment different in a transplanted liver?
After a transplant, you take medicines that calm the immune system so the new liver is not rejected. Those medicines change what treatment is safe if HCC returns. Every decision has to be made jointly by your oncologist and the transplant centre that looks after you.
Who immunotherapy may not suit
Immunotherapy medicines such as atezolizumab work by releasing the brakes on the immune system. In someone with a transplanted liver, that can trigger rejection of the new organ, which can be life-threatening. For that reason, immunotherapy is generally avoided after a liver transplant, or used only after a very careful discussion of the risk. Tablets such as sorafenib or lenvatinib are more often considered. How these medicines work is covered on immunotherapy for HCC.
The anti-rejection medicines themselves
Some transplant teams adjust the anti-rejection medicines when cancer returns. That decision belongs to the transplant hepatologist. Never stop or change these medicines yourself.
If you have had a transplant, tell every doctor who treats you, including for a cold or a fever.Commonly believed
What families often fear, and what is actually true
"It came back, so the first treatment was a waste."
The first treatment removed or destroyed the tumour that was there. A new tumour often comes from the liver damage that remains, not from a failed treatment.
"Once it returns, nothing more can be done."
Many people have a second, and sometimes a third, local treatment. When local treatment no longer fits, systemic treatment is still an option for many.
"A transplant means the cancer can never come back."
A transplant removes the damaged liver, so new tumours from old liver disease become unlikely. Cells that had already escaped can still grow, which is why follow-up continues after a transplant.
"If my AFP is normal, the scan does not matter."
Some liver cancers never raise AFP. A normal result does not replace a scan, so keep both on schedule.
Being straight with you
What this page cannot tell you
It cannot tell you whether the spot on your scan is cancer, whether it is recurrence or a new tumour, or what to expect for yourself. Those answers need your scans laid side by side, your liver blood tests and a team who knows your earlier treatment.
Who this page does not apply to
It does not apply to cancer that spread to the liver from another organ, to bile duct cancer, or to children treated for hepatoblastoma. It is also not a guide to choosing your own treatment. Options depend on details no general page can weigh.
Who can answer your questions
Your medical oncologist and the team that treated you first, and your transplant centre if you had a transplant. At CION the tumour board can review the new scans, and a second opinion on the plan can be arranged. Hepatitis B or C treatment continues with your hepatologist throughout.
Questions we are asked
Common questions about HCC after treatment
Does a new spot on my follow-up scan mean the cancer is back?
Not always. It may be recurrence, a new tumour, or a scar or change from earlier treatment. Your team compares it with older scans and may ask for a different or repeat scan. Do not wait for the next routine visit; ask for the report to be reviewed now.
Why does liver cancer come back so often?
Because the liver around the tumour is usually still damaged by hepatitis, fatty liver or cirrhosis. Treating one tumour does not repair that damage. Keeping hepatitis B controlled, treating hepatitis C and avoiding alcohol can lower the chance of a new tumour.
Can I have surgery again?
Sometimes. A repeat resection is possible if the new tumour can be reached and enough healthy liver will remain. CION's surgical oncologists assess this, and your team will tell you where the operation takes place. Ablation or TACE may be alternatives.
What is a salvage transplant?
It is a liver transplant offered to some people whose HCC returns after surgery, if they meet the transplant centre's criteria. Licensed transplant centres decide eligibility, and rules change. See the page on salvage transplant for more.
Can immunotherapy be used after a liver transplant?
It is generally avoided, because it can cause the body to reject the new liver. In rare cases it is discussed after a careful talk about that risk. Your oncologist and transplant team must decide together. Never start or stop any medicine on your own.
Does recurrence mean the first doctors made a mistake?
Usually not. Tiny cancer deposits can be too small for any scan to see, and new tumours arise from the liver disease itself. Recurrence is a known part of HCC, which is why close follow-up is planned from the start.
Should I keep taking my hepatitis B tablets?
Yes, unless your hepatologist or physician tells you otherwise. Hepatitis B is controlled, not removed, and stopping antiviral tablets can cause a dangerous flare. Keeping the virus quiet also protects the liver you still have.
How can CION help if my cancer has come back?
CION can review your new and old scans at the tumour board, offer a second opinion, and give systemic treatment. Scans, biopsy, TACE, ablation and surgery are coordinated through accredited partner hospitals. One helpline serves every CION centre.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — After Liver Cancer Treatment
- American Cancer Society — Cancer Recurrence
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
- NIDDK — Liver Transplant - NIDDK
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Recurrence or a brand new tumour?Why the difference changes the planTreatment options if it comes backEvery option, laid out for a returning cancerCancer coming back after a transplantThe transplant-specific questions in detailRepeat resection, repeat ablation, repeat TACEWhen the same treatment can be used again
Talk to us
Has a follow-up scan shown something new?
Send us your new and earlier scans and the tumour board will review what the finding means and which options remain. You do not have to wait for your next routine visit. One helpline serves every CION centre.